Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Vigabatrin in Infants With Infantile Spasms
NCT01413711Phase 4Withdrawn
- Sponsor
- Lundbeck
- Start
- Jun 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of vigabatrin in infantile epileptic spasms syndrome (IESS), sponsored by Lundbeck. Planned start Jun 2012; status: withdrawn.
02
Drugs
vigabatrin
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT01413711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01413711.